Market Update (NASDAQ:BIIB): Biogen Idec Second Quarter 2014 Revenues Increase 40% to $2.4 Billion; Company Raises Financial Guidance for the Year
July 23, 2014 at 06:45 AM EDT
[Business Wire] – Biogen Idec Inc. today reported second quarter 2014 results, including revenue of $2.4 billion, a 40% increase compared to the second quarter of 2013. Second quarter 2014 non-GAAP diluted earnings . . . → Read More: Market Update (NASDAQ:BIIB): Biogen Idec Second Quarter 2014 Revenues Increase 40% to $2.4 Billion; Company Raises Financial Guidance for the Year Similar Articles: Biogen Idec Inc (NASDAQ:BIIB) | ISIS Pharmaceuticals’ and Biogen idec’s innovative collaboration voted breakthrough alliance of 2014 Stock Update (NASDAQ:BIIB): Biogen Idec to Report First Quarter 2014 Financial Results on April 23, 2014 Stock Update: Wal-Mart Stores Inc (NYSE:WMT) – Walmart updates FY 14 underlying EPS guidance for fourth quarter and full year